Table 1

PBSC graft cell subset frequencies and cell doses from 78 healthy donors

Frequencies of graft cell subsets, (%)
Doses of graft cell subsets infused, 106 cells/kg of body weight
Mean ± SDMedian (min-max)Mean ± SDMedian (min-max)
CD34+ 2.1 ± 1.7 1.6 (0.4-12.6) 5.9 ± 2.8 5.7 (1.1-16.8) 
NK cells 3.6 ± 2.5 3.2 (0.5-18.4) 13.2 ± 12.3 10.5 (0.46-80.8) 
B cells 11.9 ± 6.5 10.5 (0.9-34.8) 46.1 ± 52.1 33.9 (5.1-162.3) 
T cells 45.6 ± 11.4 45.30 (21.8-75.4) 170.5 ± 119 145 (16.8-684.1) 
CD4+ T cells 30.4 ± 8.6 29.8 (12.6-56.5) 115 ± 86.9 89.9 (8.8-511) 
CD8+ T cells 13.1 ± 5.8 11.8 (4.1-29.2) 47.7 ± 34.6 36.8 (5.4-154) 
Tregs 3.8 ± 1.6 3.5 (0.9-8.2) 6.68 ± 6.5 4.8 (0.4-41.3) 
CD3+CD161+ 12.7 ± 6.9 12.6 (1.6-32.6) 10.1 ± 11.3 6.4 (0.6-62.1) 
iNKT cells 0.139 ± 0.23 0.043 (0.001-1.07) 0.2 ± 0.312 0.052 (0.002-1.4) 
iNKT CD4 0.091 ± 0.175 0.019 (0.001-0.76) 0.113 ± 0.2 0.031 (0.001-1.04) 
iNKT CD4+ 0.061 ± 0.12 0.015 (0.001-0.68) 0.091 ± 0.175 0.025 (0.001-1.09) 
Frequencies of graft cell subsets, (%)
Doses of graft cell subsets infused, 106 cells/kg of body weight
Mean ± SDMedian (min-max)Mean ± SDMedian (min-max)
CD34+ 2.1 ± 1.7 1.6 (0.4-12.6) 5.9 ± 2.8 5.7 (1.1-16.8) 
NK cells 3.6 ± 2.5 3.2 (0.5-18.4) 13.2 ± 12.3 10.5 (0.46-80.8) 
B cells 11.9 ± 6.5 10.5 (0.9-34.8) 46.1 ± 52.1 33.9 (5.1-162.3) 
T cells 45.6 ± 11.4 45.30 (21.8-75.4) 170.5 ± 119 145 (16.8-684.1) 
CD4+ T cells 30.4 ± 8.6 29.8 (12.6-56.5) 115 ± 86.9 89.9 (8.8-511) 
CD8+ T cells 13.1 ± 5.8 11.8 (4.1-29.2) 47.7 ± 34.6 36.8 (5.4-154) 
Tregs 3.8 ± 1.6 3.5 (0.9-8.2) 6.68 ± 6.5 4.8 (0.4-41.3) 
CD3+CD161+ 12.7 ± 6.9 12.6 (1.6-32.6) 10.1 ± 11.3 6.4 (0.6-62.1) 
iNKT cells 0.139 ± 0.23 0.043 (0.001-1.07) 0.2 ± 0.312 0.052 (0.002-1.4) 
iNKT CD4 0.091 ± 0.175 0.019 (0.001-0.76) 0.113 ± 0.2 0.031 (0.001-1.04) 
iNKT CD4+ 0.061 ± 0.12 0.015 (0.001-0.68) 0.091 ± 0.175 0.025 (0.001-1.09) 

CD34+, NK, B, T, CD4+, and CD8+ T-cell frequencies are shown as percentage of the total live cells. Tregs, CD3+CD161+, and iNKT-cell frequencies are shown as percentage of the T cells.

Close Modal

or Create an Account

Close Modal
Close Modal